BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36853387)

  • 1. Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells.
    Wang J; Zhou Z
    Discov Oncol; 2023 Feb; 14(1):28. PubMed ID: 36853387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors.
    Voutsadakis IA
    Gene; 2022 Dec; 847():146881. PubMed ID: 36100115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptor coactivator 3 transactivates proinflammatory cytokines in collagen-induced arthritis.
    Sun X; Chen J; Chen X; Ma J; Xiao L; Yao S; Dang X
    Cytokine; 2023 Jan; 161():156074. PubMed ID: 36323191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
    Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
    Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
    Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
    BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.
    Voutsadakis IA
    Gene; 2023 Mar; 857():147179. PubMed ID: 36627096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
    Nakshatri H; Bhat-Nakshatri P; Martin DA; Goulet RJ; Sledge GW
    Mol Cell Biol; 1997 Jul; 17(7):3629-39. PubMed ID: 9199297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter.
    Pradhan M; Baumgarten SC; Bembinster LA; Frasor J
    Mol Cell Biol; 2012 Jan; 32(2):569-75. PubMed ID: 22083956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCoA3 upregulation in breast cancer‑associated adipocytes elicits an inflammatory profile.
    Lira MC; Rosa FD; Aiello I; Machado MS; Palma AG; Paz L; Güemes MCS; Burlando S; Azurmendi PJ; Paladino N; Costas MA; Rubio MF
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 37026525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma.
    Burley TA; Kennedy E; Broad G; Boyd M; Li D; Woo T; West C; Ladikou EE; Ashworth I; Fegan C; Johnston R; Mitchell S; Mackay SP; Pepper AGS; Pepper C
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2α-ATF4 signalling in breast cancer.
    Gupta A; Hossain MM; Miller N; Kerin M; Callagy G; Gupta S
    Oncogene; 2016 Nov; 35(45):5860-5871. PubMed ID: 27109102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma.
    Nagy B; Lundán T; Larramendy ML; Aalto Y; Zhu Y; Niini T; Edgren H; Ferrer A; Vilpo J; Elonen E; Vettenranta K; Franssila K; Knuutila S
    Br J Haematol; 2003 Feb; 120(3):434-41. PubMed ID: 12580957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling.
    Sirinian C; Papanastasiou AD; Schizas M; Spella M; Stathopoulos GT; Repanti M; Zarkadis IK; King TA; Kalofonos HP
    Oncogene; 2018 Sep; 37(37):5101-5114. PubMed ID: 29844572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL2A1: the underdog in the BCL2 family.
    Vogler M
    Cell Death Differ; 2012 Jan; 19(1):67-74. PubMed ID: 22075983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.
    Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T
    Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.